Literature DB >> 15718869

Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function.

Sung Noh Hong1, Sun-Young Lee, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo, Jong Chul Rhee, Dongil Choi, Hyo Keun Lim, Kwang-Woong Lee, Jae Won Joh.   

Abstract

GOALS: To compare the efficacy of radiofrequency ablation (RFA) and surgical resection in a group of patients with a Child-Pugh score of 5 and a single HCC less than 4 cm in diameter.
BACKGROUND: Radiofrequency ablation (RFA) has become a popular method for treatment of hepatocellular carcinoma (HCC) and has been applied as an alternative primary therapy to surgical resection. STUDY: We compared outcomes for 148 patients treated with RFA (n = 55) and those treated surgically (n = 93).
RESULTS: The rate of local recurrence among patients in the RFA group was significantly higher than in the surgery group (P = 0.005), while the incidence of remote recurrence was similar between the two groups (P = 0.30). The cumulative 1- and 3-year overall survival rates (P = 0.24) and the cumulative 1- and 3-year recurrence-free survival rates (P = 0.54) were not significantly different between the two groups.
CONCLUSIONS: Despite a higher rate of local recurrence, RFA was found to be as effective as surgical resection for the treatment of single small HCC in patients with well-preserved liver function, in terms of the incidence of remote recurrence and the patients' likelihood of achieving overall and/or recurrence-free survival.

Entities:  

Mesh:

Year:  2005        PMID: 15718869     DOI: 10.1097/01.mcg.0000152746.72149.31

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  60 in total

1.  Effect of interval between transcatheter hepatic arterial embolization and radiofrequency ablation on ablated lesion size in a swine model.

Authors:  Cao Guang; Nobuyuki Kawai; Morio Sato; Isao Takasaka; Hiroki Minamiguchi; Shinya Sahara; Kouhei Nakata; Tetsuo Sonomura; Shintaro Shirai; Ichiro Mori; Renjie Yang
Journal:  Jpn J Radiol       Date:  2011-09-29       Impact factor: 2.374

2.  Radiofrequency ablation in the treatment of small hepatocellular carcinoma: a meta analysis.

Authors:  Jun-Guo Liu; Yi-Jun Wang; Zhi Du
Journal:  World J Gastroenterol       Date:  2010-07-21       Impact factor: 5.742

3.  Percutaneous radiofrequency ablation versus partial hepatectomy for multicentric small hepatocellular carcinomas: a nonrandomized comparative study.

Authors:  Wei-Xing Guo; Bo Zhai; Eric C H Lai; Nan Li; Jie Shi; Wan-Yee Lau; Meng-Chao Wu; Shu-Qun Cheng
Journal:  World J Surg       Date:  2010-11       Impact factor: 3.352

4.  Recurrence and treatment pattern in long-term survivors with hepatocellular carcinoma: a comparison between radiofrequency ablation and surgery as a first-line treatment.

Authors:  Hyojin Kim; Hyunchul Rhim; Dongil Choi; Hyo K Lim; Young-Sun Kim; Won Jae Lee; Jae Won Joh
Journal:  World J Surg       Date:  2010-08       Impact factor: 3.352

Review 5.  Radiofrequency ablation versus resection for liver tumours: an evidence-based approach to retrospective comparative studies.

Authors:  Gianpiero Gravante; John Overton; Roberto Sorge; Neil Bhardwaj; Matthew S Metcalfe; David M Lloyd; Ashley R Dennison
Journal:  J Gastrointest Surg       Date:  2011-02       Impact factor: 3.452

Review 6.  Local recurrence of hepatocellular carcinoma after radiofrequency ablation.

Authors:  Wang-Jun Liao; Min Shi; Jin-Zhang Chen; Ai-Min Li
Journal:  World J Gastroenterol       Date:  2010-10-28       Impact factor: 5.742

7.  Percutaneous ablation therapy versus surgical resection in the treatment for early-stage hepatocellular carcinoma: a meta-analysis of 21,494 patients.

Authors:  Jia-yan Ni; Lin-feng Xu; Hong-liang Sun; Jing-xing Zhou; Yao-ting Chen; Jiang-hong Luo
Journal:  J Cancer Res Clin Oncol       Date:  2013-09-26       Impact factor: 4.553

8.  Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis.

Authors:  Alfredo Guglielmi; Andrea Ruzzenente; Alessandro Valdegamberi; Silvia Pachera; Tommaso Campagnaro; Mirko D'Onofrio; Enrico Martone; Paola Nicoli; Calogero Iacono
Journal:  J Gastrointest Surg       Date:  2007-11-13       Impact factor: 3.452

9.  Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection?

Authors:  L Lupo; P Panzera; G Giannelli; M Memeo; A Gentile; V Memeo
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

10.  Percutaneous radiofrequency ablation of hepatocellular carcinomas adjacent to the gallbladder with internally cooled electrodes: assessment of safety and therapeutic efficacy.

Authors:  Sang Won Kim; Hyunchul Rhim; Mihyun Park; Heejung Kim; Young-sun Kim; Dongil Choi; Hyo K Lim
Journal:  Korean J Radiol       Date:  2009-06-25       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.